A Study In Patients With Type 2 Diabetes Mellitus

GlaxoSmithKline (GSK)

Status and phase: Completed; Phase 3

Conditions: Diabetes Mellitus, Type 2

Treatments: Drug: GSK523338

Study type: Interventional

Funder types: Industry

Identifiers

NCT00256867

AVS101946

Details and patient eligibility

About

This study evaluates the effect of medicines for type 2 diabetes and lipids control. This study will require about 6 office visits for lab tests and examinations. All study related medicines and medical examinations will be provided at no cost to the subjects.

Enrollment: 369 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• A clinical diagnosis type 2 diabetes mellitus.
• Women must not be pregnant or breastfeeding during the study and 30 days after the study.
• Must sign an informed consent form at the study clinic.

Exclusion criteria

• Severe chronic diseases that would prevent from participating and completing the study by investigator's judgement.
• Use of an investigational drug within 30 days or 5 half lives before first dose of study medication.
• Insulin use for > 1 week in past 3 months.